ORAMED PHARMACEUTICALS INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mayer Arie | — | Award / Grant | 6,975 | — | — | Jun 5, 2025 |
| Aghion Daniel | — | Award / Grant | 30,000 | — | — | Jun 5, 2025 |
| Reznick Yehuda | — | Award / Grant | 30,000 | — | — | Jun 5, 2025 |
| Sank Leonard | — | Award / Grant | 6,510 | — | — | Jun 5, 2025 |
| Shapiro Benjamin | — | Award / Grant | 30,000 | — | — | Jun 5, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 74,000 | — | — | Feb 11, 2025 |
| Hexter Joshua | COO & CBO | Award / Grant | 33,334 | — | — | Feb 11, 2025 |
| KIDRON NADAV | President and CEO | Award / Grant | 186,000 | — | — | Feb 11, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 42,000 | — | — | Feb 11, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 207,000 | — | — | Jan 2, 2025 |
| KIDRON NADAV | President and CEO | Award / Grant | 433,500 | — | — | Jan 2, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 188,000 | — | — | Jan 2, 2025 |
| Hexter Joshua | COO & CBO | Award / Grant | 194,500 | — | — | Jan 2, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 30,000 | — | — | Nov 7, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 45,000 | — | — | Nov 7, 2024 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 30,000 | — | — | Nov 7, 2024 |
| Hexter Joshua | COO & CBO | Award / Grant | 30,000 | — | — | Nov 7, 2024 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 140,040 | — | — | Jun 21, 2024 |
| Reznick Yehuda | — | Award / Grant | 760 | — | — | Jun 6, 2024 |
| Reznick Yehuda | — | Award / Grant | 29,800 | — | — | Apr 17, 2024 |
| Aghion Daniel | — | Award / Grant | 3,750 | — | — | Jan 30, 2024 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 295,500 | — | — | Jan 4, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 329,000 | — | — | Jan 4, 2024 |
| Hexter Joshua | COO & CBO | Award / Grant | 180,500 | — | — | Jan 4, 2024 |
| Silberman David | Chief Financial Officer | Award / Grant | 136,500 | — | — | Jan 4, 2024 |
| Sank Leonard | — | Award / Grant | 9,325 | — | — | Jan 4, 2024 |
| Rozov Yadin | — | Award / Grant | 30,000 | — | — | Jan 4, 2024 |
| Mayer Arie | — | Award / Grant | 30,000 | — | — | Jan 4, 2024 |
| Aghion Daniel | — | Award / Grant | 5,070 | — | — | Jan 4, 2024 |
| Shapiro Benjamin | — | Award / Grant | 30,000 | — | — | Jan 4, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 120,000 | — | — | May 26, 2023 |
| Derovan Netanel | Chief Legal Officer | Award / Grant | 20,500 | — | — | May 26, 2023 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 53,500 | — | — | May 26, 2023 |
| Hexter Joshua | COO & CBO | Award / Grant | 27,000 | — | — | May 26, 2023 |
| Silberman David | Chief Financial Officer | Award / Grant | 24,500 | — | — | May 26, 2023 |
| Shapiro Benjamin | — | Award / Grant | 20,000 | — | — | May 1, 2023 |
| Sank Leonard | — | Award / Grant | 30,000 | — | — | Apr 17, 2023 |
| Derovan Netanel | Chief Legal Officer | Award / Grant | 81,000 | — | — | Apr 17, 2023 |
| Hexter Joshua | COO & CBO | Award / Grant | 108,000 | — | — | Apr 17, 2023 |
| KIDRON NADAV | President and CEO | Award / Grant | 279,000 | — | — | Apr 17, 2023 |
| Rozov Yadin | — | Award / Grant | 30,000 | — | — | Apr 17, 2023 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 213,000 | — | — | Apr 17, 2023 |
| Silberman David | Chief Financial Officer | Award / Grant | 97,500 | — | — | Apr 17, 2023 |
| Mayer Arie | — | Award / Grant | 30,000 | — | — | Apr 17, 2023 |
| Mayer Arie | — | Purchase | 5,009 | $2.22 | $11,120 | Apr 4, 2023 |
| KIDRON NADAV | President and CEO | Purchase | 26,000 | $2.04 | $53,040 | Mar 16, 2023 |
| KIDRON NADAV | President and CEO | Purchase | 100,000 | $2.01 | $201,000 | Mar 14, 2023 |
| Kidron Miriam | Chief Scientific Officer | Sale | 100,000 | $2.01 | $201,000 | Mar 14, 2023 |
| Rozov Yadin | — | Purchase | 20,000 | $1.96 | $39,200 | Mar 14, 2023 |
| Rabinowitz Michael | Chief Commercial Officer | Sale | 1,425 | $13.01 | $18,539 | Jan 3, 2023 |